Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 214

1.

Relationship between disability and health-related quality of life and caregiver burden in patients with upper limb poststroke spasticity.

Doan QV, Brashear A, Gillard PJ, Varon SF, Vandenburgh AM, Turkel CC, Elovic EP.

PM R. 2012 Jan;4(1):4-10. doi: 10.1016/j.pmrj.2011.10.001. Epub 2011 Dec 24.

PMID:
22200567
2.

Repeated treatments with botulinum toxin type a produce sustained decreases in the limitations associated with focal upper-limb poststroke spasticity for caregivers and patients.

Elovic EP, Brashear A, Kaelin D, Liu J, Millis SR, Barron R, Turkel C.

Arch Phys Med Rehabil. 2008 May;89(5):799-806. doi: 10.1016/j.apmr.2008.01.007.

PMID:
18452724
3.

BoTULS: a multicentre randomised controlled trial to evaluate the clinical effectiveness and cost-effectiveness of treating upper limb spasticity due to stroke with botulinum toxin type A.

Shaw L, Rodgers H, Price C, van Wijck F, Shackley P, Steen N, Barnes M, Ford G, Graham L; BoTULS investigators.

Health Technol Assess. 2010 May;14(26):1-113, iii-iv. doi: 10.3310/hta14260.

4.

Caregiver burden, productivity loss, and indirect costs associated with caring for patients with poststroke spasticity.

Ganapathy V, Graham GD, DiBonaventura MD, Gillard PJ, Goren A, Zorowitz RD.

Clin Interv Aging. 2015 Nov 6;10:1793-802. doi: 10.2147/CIA.S91123. eCollection 2015.

5.

Predicting sickness impact profile at six months after stroke: further results from the European multi-center CERISE study.

Stummer C, Verheyden G, Putman K, Jenni W, Schupp W, De Wit L.

Disabil Rehabil. 2015;37(11):942-50. doi: 10.3109/09638288.2014.948137. Epub 2014 Aug 29.

PMID:
25170786
6.

Quality-of-life and disability in patients with stroke.

Cerniauskaite M, Quintas R, Koutsogeorgou E, Meucci P, Sattin D, Leonardi M, Raggi A.

Am J Phys Med Rehabil. 2012 Feb;91(13 Suppl 1):S39-47. doi: 10.1097/PHM.0b013e31823d4df7.

PMID:
22193309
7.

Botulinum toxin type A in post-stroke upper limb spasticity.

Kaji R, Osako Y, Suyama K, Maeda T, Uechi Y, Iwasaki M; GSK1358820 Spasticity Study Group.

Curr Med Res Opin. 2010 Aug;26(8):1983-92. doi: 10.1185/03007995.2010.497103.

PMID:
20569068
8.

Combined life satisfaction of persons with stroke and their caregivers: associations with caregiver burden and the impact of stroke.

Bergström AL, Eriksson G, von Koch L, Tham K.

Health Qual Life Outcomes. 2011 Jan 11;9:1. doi: 10.1186/1477-7525-9-1.

9.

Anxiety and depression associated with caregiver burden in caregivers of stroke survivors with spasticity.

Denno MS, Gillard PJ, Graham GD, DiBonaventura MD, Goren A, Varon SF, Zorowitz R.

Arch Phys Med Rehabil. 2013 Sep;94(9):1731-6. doi: 10.1016/j.apmr.2013.03.014. Epub 2013 Mar 30.

PMID:
23548544
10.

Does botulinum toxin type A decrease pain and lessen disability in hemiplegic survivors of stroke with shoulder pain and spasticity?: a randomized, double-blind, placebo-controlled trial.

Marciniak CM, Harvey RL, Gagnon CM, Duraski SA, Denby FA, McCarty S, Bravi LA, Polo KM, Fierstein KM.

Am J Phys Med Rehabil. 2012 Dec;91(12):1007-19. doi: 10.1097/PHM.0b013e31826ecb02.

PMID:
23064478
11.

Inter- and intrarater reliability of the Ashworth Scale and the Disability Assessment Scale in patients with upper-limb poststroke spasticity.

Brashear A, Zafonte R, Corcoran M, Galvez-Jimenez N, Gracies JM, Gordon MF, McAfee A, Ruffing K, Thompson B, Williams M, Lee CH, Turkel C.

Arch Phys Med Rehabil. 2002 Oct;83(10):1349-54.

PMID:
12370866
12.

Functioning at 6 months post stroke following discharge from inpatient rehabilitation.

Rouillard S, De Weerdt W, De Wit L, Jelsma J.

S Afr Med J. 2012 May 23;102(6):545-8.

PMID:
22668960
13.

Poststroke spasticity: sequelae and burden on stroke survivors and caregivers.

Zorowitz RD, Gillard PJ, Brainin M.

Neurology. 2013 Jan 15;80(3 Suppl 2):S45-52. doi: 10.1212/WNL.0b013e3182764c86. Review.

PMID:
23319485
14.

Efficacy of coupling repetitive transcranial magnetic stimulation and physical therapy to reduce upper-limb spasticity in patients with stroke: a randomized controlled trial.

Barros Galvão SC, Borba Costa dos Santos R, Borba dos Santos P, Cabral ME, Monte-Silva K.

Arch Phys Med Rehabil. 2014 Feb;95(2):222-9. doi: 10.1016/j.apmr.2013.10.023. Epub 2013 Nov 12.

PMID:
24239881
15.

Long-term efficacy and safety of incobotulinumtoxinA and conventional treatment of poststroke arm spasticity: a prospective, non-interventional, open-label, parallel-group study.

Dressler D, Rychlik R, Kreimendahl F, Schnur N, Lambert-Baumann J.

BMJ Open. 2015 Dec 30;5(12):e009358. doi: 10.1136/bmjopen-2015-009358.

16.

Outcomes of ambulatory rehabilitation programmes following botulinum toxin for spasticity in adults with stroke.

Demetrios M, Gorelik A, Louie J, Brand C, Baguley IJ, Khan F.

J Rehabil Med. 2014 Sep;46(8):730-7. doi: 10.2340/16501977-1842.

17.

Quality of life of stroke survivors and their informal caregivers: A prospective study.

Chuluunbaatar E, Chou YJ, Pu C.

Disabil Health J. 2016 Apr;9(2):306-12. doi: 10.1016/j.dhjo.2015.10.007. Epub 2015 Dec 1.

PMID:
27017120
18.

Physical disability contributes to caregiver stress in dementia caregivers.

Bruce DG, Paley GA, Nichols P, Roberts D, Underwood PJ, Schaper F.

J Gerontol A Biol Sci Med Sci. 2005 Mar;60(3):345-9.

PMID:
15860472
19.

Application of a volar static splint in poststroke spasticity of the upper limb.

Pizzi A, Carlucci G, Falsini C, Verdesca S, Grippo A.

Arch Phys Med Rehabil. 2005 Sep;86(9):1855-9.

PMID:
16181954
20.

Rationale and design of a multicentre, double-blind, prospective, randomized, European and Canadian study: evaluating patient outcomes and costs of managing adults with post-stroke focal spasticity.

Borg J, Ward AB, Wissel J, Kulkarni J, Sakel M, Ertzgaard P, Åkerlund P, Reuter I, Herrmann C, Satkunam L, Wein T, Girod I, Wright N; BEST Study Group.

J Rehabil Med. 2011 Jan;43(1):15-22. doi: 10.2340/16501977-0663.

Supplemental Content

Support Center